{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:12:46Z","timestamp":1694005966192},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00117-017-0245-8","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T11:59:15Z","timestamp":1493035155000},"page":"659-664","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hochintensiver fokussierter Ultraschall (HIFU)"],"prefix":"10.1007","volume":"57","author":[{"given":"R.","family":"Ganzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"245_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","volume":"112","author":"PK Agarwal","year":"2008","unstructured":"Agarwal PK, Sadetsky N, Konety BR et\u00a0al (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112:307\u2013314","journal-title":"Cancer"},{"key":"245_CR2","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","volume":"361","author":"HU Ahmed","year":"2009","unstructured":"Ahmed HU (2009) The index lesion and the origin of prostate cancer. N\u00a0Engl J Med 361:1704\u20131706","journal-title":"N Engl J Med"},{"key":"245_CR3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","volume":"13","author":"HU Ahmed","year":"2012","unstructured":"Ahmed HU, Hindley RG, Dickinson L et\u00a0al (2012) Focal therapy for localised unifocal and multifocal prostate cancer: a\u00a0prospective development study. Lancet Oncol 13:622\u2013632","journal-title":"Lancet Oncol"},{"key":"245_CR4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bju.12545","volume":"114","author":"E Baco","year":"2014","unstructured":"Baco E, Gelet A, Crouzet S et al (2014) Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a\u00a0prospective two-centre study. BJU Int 114:532\u2013540","journal-title":"BJU Int"},{"key":"245_CR5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1464-410X.2009.08518.x","volume":"104","author":"A Blana","year":"2009","unstructured":"Blana A, Brown SC, Chaussy C et al (2009) High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int 104:1058\u20131062","journal-title":"BJU Int"},{"key":"245_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11934-003-0077-0","volume":"4","author":"C Chaussy","year":"2003","unstructured":"Chaussy C, Thuroff S (2003) The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a\u00a0combined resection. Curr Urol Rep 4:248\u2013252","journal-title":"Curr. Urol. Rep."},{"key":"245_CR7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.radonc.2012.09.014","volume":"105","author":"S Crouzet","year":"2012","unstructured":"Crouzet S, Murat FJ, Pommier P et al (2012) Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. Radiother Oncol 105:198\u2013202","journal-title":"Radiother Oncol"},{"key":"245_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOU.0000000000000053","volume":"24","author":"S Crouzet","year":"2014","unstructured":"Crouzet S, Rouviere O, Martin X et al (2014) High-intensity focused ultrasound as focal therapy of prostate cancer. Curr Opin Urol 24:225\u2013230","journal-title":"Curr Opin Urol"},{"key":"245_CR9","doi-asserted-by":"crossref","unstructured":"Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhai L (2007) International Task Force on Prostate Cancer and the Focal Lesion Paradigm. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J\u00a0Urol. 178(6):2260\u20132267","DOI":"10.1016\/j.juro.2007.08.072"},{"key":"245_CR10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/end.2009.0596","volume":"24","author":"J Rosette De La","year":"2010","unstructured":"De La Rosette J, Ahmed H, Barentsz J et al (2010) Focal therapy in prostate cancer-report from a\u00a0consensus panel. J\u00a0Endourol 24:775\u2013780","journal-title":"J Endourol"},{"key":"245_CR11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.eururo.2016.02.054","volume":"70","author":"L Dickinson","year":"2016","unstructured":"Dickinson L, Arya M, Afzal N et al (2016) Medium-term outcomes after whole-gland high-intensity focused ultrasound for the treatment of Nonmetastatic prostate cancer from a\u00a0multicentre registry cohort. Eur Urol 70:668\u2013674","journal-title":"Eur Urol"},{"key":"245_CR12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","volume":"67","author":"IA Donaldson","year":"2015","unstructured":"Donaldson IA, Alonzi R, Barratt D et\u00a0al (2015) Focal therapy: patients, interventions, and outcomes \u2013 a report from a\u00a0consensus meeting. Eur Urol 67:771\u2013777","journal-title":"Eur. Urol."},{"issue":"3","key":"245_CR13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2007.07.010","volume":"53","author":"R Ganzer","year":"2007","unstructured":"Ganzer R, Rogenhofer S, Walter B et al (2007) PSA nadir is a\u00a0significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. EurUrol 53(3):547","journal-title":"Eur.Urol"},{"key":"245_CR14","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1111\/j.1464-410X.2011.10091.x","volume":"108","author":"R Ganzer","year":"2011","unstructured":"Ganzer R, Robertson CN, Ward JF et al (2011) Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria \u2013 analysis from the @\u2011Registry. BJU Int 108:E196\u2013E201","journal-title":"BJU Int"},{"key":"245_CR15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1464-410X.2012.11715.x","volume":"112","author":"R Ganzer","year":"2013","unstructured":"Ganzer R, Fritsche HM, Brandtner A et al (2013) Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer. BJU Int 112:322\u2013329","journal-title":"BJU Int"},{"key":"245_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijrobp.2009.05.068","volume":"77","author":"H Isbarn","year":"2010","unstructured":"Isbarn H, Karakiewicz PI, Vogel S et al (2010) Unilateral prostate cancer cannot be accurately predicted in low-risk patients. Int J Radiat Oncol Biol Phys 77:784\u2013787","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"245_CR17","first-page":"342","volume":"4","author":"L Klotz","year":"2015","unstructured":"Klotz L (2015) Active surveillance and focal therapy for low-intermediate risk prostate cancer. Transl Androl Urol 4:342\u2013354","journal-title":"Transl Androl Urol"},{"key":"245_CR18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","volume":"67","author":"JD Le","year":"2015","unstructured":"Le JD, Tan N, Shkolyar E et al (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67:569\u2013576","journal-title":"Eur. Urol."},{"key":"245_CR19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2008.04.091","volume":"55","author":"FJ Murat","year":"2009","unstructured":"Murat FJ, Poissonnier L, Rabilloud M et al (2009) Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 55:640\u2013647","journal-title":"Eur Urol"},{"key":"245_CR20","doi-asserted-by":"crossref","unstructured":"Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS (2017) Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology. J\u00a0Urol. 197(2):320\u2013326","DOI":"10.1016\/j.juro.2016.07.084"},{"key":"245_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.eururo.2016.09.039","volume":"71","author":"P Rischmann","year":"2017","unstructured":"Rischmann P, Gelet A, Riche B et\u00a0al (2017) Focal high intensity focused ultrasound of unilateral localized prostate cancer: a prospective multicentric hemiablation study of 111 patients. Eur Urol 71:267\u2013273","journal-title":"Eur. Urol."},{"key":"245_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.juro.2016.06.092","volume":"197","author":"KM Siddiqui","year":"2017","unstructured":"Siddiqui KM, Billia M, Arifin A et\u00a0al (2017) Pathological, oncologic and functional outcomes of a\u00a0prospective registry of salvage high intensity focused ultrasound ablation for radiorecurrent prostate cancer. J\u00a0Urol 197:97\u2013102","journal-title":"J Urol"},{"key":"245_CR23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.juro.2013.02.010","volume":"190","author":"S Thuroff","year":"2013","unstructured":"Thuroff S, Chaussy C (2013) Evolution and outcomes of 3\u202fMHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. J\u00a0Urol 190:702\u2013710","journal-title":"J Urol"},{"key":"245_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","volume":"66","author":"M Valerio","year":"2014","unstructured":"Valerio M, Ahmed HU, Emberton M et\u00a0al (2014) The role of focal therapy in the management of localised prostate cancer: a\u00a0systematic review. Eur Urol 66:732\u2013751","journal-title":"Eur. Urol."},{"key":"245_CR25","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/01.ju.0000124880.35944.58","volume":"171","author":"G Vallancien","year":"2004","unstructured":"Vallancien G, Prapotnich D, Cathelineau X et\u00a0al (2004) Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. JUrol 171:2265\u20132267","journal-title":"J.Urol."},{"key":"245_CR26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.eururo.2014.01.001","volume":"65","author":"W Bos Van Den","year":"2014","unstructured":"Van Den Bos W, Muller BG, Ahmed H et\u00a0al (2014) Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. Eur Urol 65:1078\u20131083","journal-title":"Eur Urol"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-017-0245-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-017-0245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-017-0245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T07:39:22Z","timestamp":1502091562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-017-0245-8"}},"subtitle":["Stellenwert bei der Therapie des Prostatakarzinoms"],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1007\/s00117-017-0245-8","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]}}}